Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -18.86%2.69M | 13.36%6.56M | 186.43%1.59M | 32.14%11.57M | 348.48%4.3M | 42.06%3.32M | 9.81%5.79M | -163.74%-1.84M | -42.38%8.76M | -1.73M |
| Net profit before non-cash adjustment | 242.13%3.06M | 84.61%-1.03M | 89.39%-839K | -511.16%-20.42M | -921.68%-3.65M | 31.28%-2.15M | -227.32%-6.71M | -348.32%-7.91M | -60.52%4.97M | ---356.84K |
| Total adjustment of non-cash items | 25.97%4.08M | 43.17%4.27M | 44.72%3.74M | 55.98%13.12M | 78.92%4.31M | 82.77%3.24M | 54.83%2.98M | 12.33%2.59M | 55.67%8.41M | --2.41M |
| -Depreciation and amortization | 33.53%3.82M | 20.23%3.29M | 49.40%3.48M | 59.01%11.73M | 87.83%3.81M | 63.44%2.86M | 67.93%2.74M | 18.05%2.33M | 62.50%7.38M | --2.03M |
| -Reversal of impairment losses recognized in profit and loss | --0 | --0 | --0 | 231.18%381.68K | 272.31%380.68K | --0 | --0 | -92.31%1K | 147.07%115.25K | --102.25K |
| -Disposal profit | ---22K | 69,600.00%697K | --0 | 1,221.59%248.39K | 232.10%248.39K | --0 | --1K | 88.89%-1K | 197.14%18.8K | --74.8K |
| -Other non-cash items | -25.40%282K | 15.06%275K | 2.70%266K | -15.95%752.93K | -159.50%-123.07K | 447.83%378K | -18.43%239K | -20.80%259K | 7.47%895.82K | --206.82K |
| Changes in working capital | -298.44%-4.44M | -65.03%3.33M | -137.83%-1.32M | 508.79%18.88M | 195.93%3.63M | -39.51%2.24M | 594.80%9.52M | 233.65%3.49M | -66.04%-4.62M | ---3.78M |
| -Change in receivables | -241.24%-822K | -107.06%-531K | 47.83%-1.42M | 183.17%4.98M | 93.13%-408.8K | -86.03%582K | 445.93%7.52M | -34.49%-2.72M | -80.80%-5.98M | ---5.95M |
| -Change in inventory | -507.49%-1.09M | -418.84%-220K | 221.01%167K | -41.50%445.34K | -89.11%247.34K | 118.45%267K | -75.09%69K | 59.29%-138K | 178.24%761.31K | --2.27M |
| -Change in payables | 247.93%1.25M | 237.46%2.94M | -324.52%-1.04M | -152.97%-1.34M | -49.50%1.18M | -290.32%-845K | -3,295.52%-2.14M | 248.09%465K | 68.00%2.53M | --2.34M |
| -Changes in other current assets | -269.25%-3.78M | -72.05%1.14M | -83.37%978K | 866.92%14.8M | 207.00%2.61M | 316.01%2.23M | 4,474.19%4.07M | 8,550.00%5.88M | -28,139.39%-1.93M | ---2.44M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -6.23%-426K | -20.16%-459K | -42.76%-414K | 1.09%-1.5M | 6.08%-423.85K | -2.30%-401K | -29.49%-382K | 22.67%-290K | -62.08%-1.51M | -451.31K |
| Interest received (cash flow from operating activities) | 4,700.00%144K | 360.00%184K | 2,860.00%148K | 92.06%754.1K | 299.74%706.1K | -98.48%3K | 40K | -73.68%5K | 1,063.44%392.64K | 176.64K |
| Tax refund paid | 22.10%-705K | 113.73%39K | 73.42%-80K | 60.04%-1.49M | -98.91%432 | 48.26%-905K | 57.99%-284K | 77.57%-301K | -65.69%-3.73M | 39.72K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -15.37%1.71M | 22.53%6.33M | 151.22%1.24M | 138.91%9.34M | 333.16%4.58M | 413.23%2.02M | 20.05%5.16M | -305.00%-2.42M | -67.56%3.91M | ---1.96M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -6.30%-4.12M | 42.43%-1.83M | 156.99%1.05M | 20.46%-12.89M | 46.56%-3.99M | 47.52%-3.88M | -513.49%-3.18M | -120.50%-1.84M | -128.35%-16.2M | ---7.46M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | ---37 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net changes in other investments | ---- | ---- | ---- | -1,058.03%-1.29M | ---- | ---- | ---- | ---- | ---111.24K | ---- |
| Investing cash flow | -6.30%-4.12M | 42.43%-1.83M | 156.99%1.05M | 13.10%-14.18M | 30.34%-5.28M | 47.52%-3.88M | -513.49%-3.18M | -120.50%-1.84M | -157.10%-16.31M | ---7.58M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | --0 | -511.02%-5M | --457K | 156.38%1.53M | 6.43%-2.1M | 1,657.42%2.41M | 1,380.00%1.22M | --0 | -115.62%-2.71M | ---2.25M |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 9,451.85%47.86M | ---1.95M |
| Increase or decrease of lease financing | 175.07%1.32M | 20.05%-1.31M | -33.02%-1.86M | 21.10%-7.1M | -51.60%-2.32M | 62.58%-1.75M | -46.86%-1.64M | 16.66%-1.4M | -111.03%-9M | ---1.53M |
| Issuance fees | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---1.95M | --0 |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,450.51%-1.19M | --1.02K |
| Financing cash flow | 99.09%1.32M | -1,401.43%-6.31M | -0.29%-1.4M | -115.95%-5.58M | -17.08%-4.42M | -98.46%661K | 65.26%-420K | 54.60%-1.4M | 531.75%34.96M | ---3.78M |
| Net cash flow | ||||||||||
| Beginning cash position | -3.64%25.29M | 9.79%27.1M | -13.60%26.22M | 293.97%30.23M | -42.48%25.05M | 249.10%26.25M | 399.13%24.69M | 295.40%30.34M | -23.78%7.67M | --43.55M |
| Current changes in cash | 8.44%-1.1M | -216.43%-1.81M | 115.70%888K | -146.16%-10.41M | 61.57%-5.12M | -103.32%-1.2M | -39.42%1.56M | -107.33%-5.66M | 1,042.49%22.56M | ---13.32M |
| End cash Position | -3.41%24.19M | -3.64%25.29M | 9.79%27.1M | -34.44%19.82M | -34.44%19.82M | -42.48%25.05M | 249.10%26.25M | 399.13%24.69M | 293.97%30.23M | --30.23M |
| Free cash flow | 103.33%63K | 145.00%4.58M | 94.91%-279K | 68.56%-3.9M | 116.81%1.6M | 72.97%-1.89M | -52.42%1.87M | -2,897.96%-5.48M | -350.46%-12.4M | ---9.54M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.